Improving lipid management in patients with acute coronary syndrome : The ACS Lipid EuroPath tool
Sionis, Alessandro (Institut d'Investigació Biomèdica Sant Pau)
Catapano, Alberico L. (University of Milan)
De Ferrari, Gaetano M. (Azienda Ospedaliero Universitaria Città Della Salute e Della Scienza di Torino)
Dudek, Dariusz (Jagiellonian University Hospital)
Jukema, J. Wouter (Leiden University Medical Center)
Landmesser, Ulf (Charité University Medicine Berlin)
Pirillo, Angela (Bassini Hospital)
Schiele, François (CHU of Besançon)
Zaman, Azfar (Newcastle Upon Tyne Hospital NHS Foundation Trust)
Zamorano, Jose L. (Hospital Universitario Ramón y Cajal (Madrid))
Universitat Autònoma de Barcelona

Data:	2020
Resum:	Post-acute coronary syndrome (ACS) patients are at very high risk for recurrent events and mortality, despite the availability of effective pharmacological approaches. In 2018, the ACS EuroPath Survey, performed in collaboration with 555 European cardiologists, identified a sub-optimal LDL-C management in post-ACS patients. Based on these premises, the ACS EuroPath II project led to the development of a self-assessment tool to improve lipid management in these very high risk patients, taking into consideration the new 2019 ESC/EAS guidelines. This tool is built in 3 sections. The first is a questionnaire to assess the lipid management practice from the acute phase up to 12 months of follow-up. The main topics covered in this section relate to 1) acute phase (lipid management of ACS patients during hospitalization; 2) discharge (lipid management at discharge, with focus on follow-up plan); 3) follow-up (lipid management at the time of first and subsequent follow-ups); 4) referral pathway for definitive lipid management care of post-ACS patients; 5) evaluation of the achieved goal at 6 months to 1 year and key implications. The second section is a brief report to position the results against other European Union clinical practice and European guidelines. The last section allows the physician to evaluate and consider the implementation of one or more strategies, successfully developed in leading European centers, in order to optimize their own clinical practice.
Drets:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, i la comunicació pública de l'obra, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. No es permet la creació d'obres derivades.
Llengua:	Anglès
Document:	Article ; recerca ; Versió publicada
Matèria:	Acute coronary syndrome ; Dyslipidemia ; Guidelines ; Lipids ; Self-assessment
Publicat a:	Atherosclerosis Supplements, Vol. 42 (december 2020) , p. e65-e71, ISSN 1878-5050

DOI: 10.1016/j.atherosclerosissup.2021.01.011
PMID: 33589227

7 p, 3.0 MB

El registre apareix a les col·leccions:
Documents de recerca > Documents dels grups de recerca de la UAB > Centres i grups de recerca (producció científica) > Ciències de la salut i biociències > Institut de Recerca Sant Pau
Articles > Articles de recerca
Articles > Articles publicats